微信直播

Paul Ness教授:多问多思考,多交益友多学习

Published at: 2015年第1卷第S1期

连海玲 , 钟珊珊
关键词:

编者按:7月13日至14日,广东省血液安全培训班在广州圆满召开。本次会议集结了国内外多位著名的血液安全、流行病研究领域专家,就“血液安全”问题展开了深入探讨。来自美国约翰霍普金斯大学医学院病理学、医学和肿瘤学的Paul Ness教授,作为本会的特邀讲者,也百忙中远道而来参加此次会议,在会上就“Pathogen inactivation and blood safety”一题进行了精彩、深入的分享,获得观众一致好评。Ness教授是输血领域最有影响力的杂志之一Transfusion杂志的主编,也是AME旗下杂志Annals of Blood的编委,对病原体灭活及血液安全有着丰富的研究经验和深刻的研究认识。会后,我们有幸采访了Ness教授,分享他对血液安全一些热点问题的看法。

人物聚焦

Dr.Paul Ness is a professor of pathology, medicine and oncology at the Johns Hopkins University School of Medicine and an editor of Transfusion. Dr.Ness earned his M.D. from State University of New York at Buffalo. His area of clinical expertise includes transfusion support of hematology and oncology patients and autoimmune hematologic disorders. Dr. Ness serves as the director of the Division of Transfusion Medicine and program director of the Blood Banking/Transfusion Medicine Fellowship Program in the Department of Pathology. Dr. Ness has an extensive background in clinical transfusion medicine and research activities related to blood safety and he has extensive experience in blood safety education programs internationally. 

采访问题:

Q1

Would you like to briefly introduce yourself, your specialties and interests to our readers?

Q2

You had an excellent presentation on the topic “Pathogen inactivation and blood safety” today. Would you like to summarize some main points with us?

Q3

China has not applied pathogen inactivation so far due to various limitation. Would you like to talk about its advantages and challenges?

Q4

Comparing Chinese and American blood centers, what do you think are their characteristics and advantages respectively?

Q5

Would you like to talk about your experiences in establishing or sustaining international programs in transfusion in Asia and Africa?

Q6

I read from an interview that your primary interest is engineer. What encouraged you to make the decision to focus on medicine? 

Q7

What would be your piece of advice for young experts?

Q8

What’s the core competence of the journal Transfusion? As for Annals of Blood, would you like to share your advice for its future development?

作为约翰霍普金斯大学医学院病理学、医学和肿瘤学教授,Ness教授先概括了他在此次会议中的演讲要点(图1),包括:病菌减少的重要性及血液安全成分等。Ness教授指出他们致力于使输血更安全,并将关注点同时放在感染性并发症和输血引发的一些免疫并发症上。

图1. Paul Ness教授讲课

谈到病原体灭活技术的优势及挑战时,Ness教授表示美国在这方面有专门的管理机制,并且他们可以在血浆成分上运用病原体灭活技术。Ness教授谈到中美血液中心的差异时,他认为中国血液中心取得了许多进步,比如推进了新的检测计划、对献血者的要求自由化、提高了献血者的信赖等。他谈到,相比于美国,在中国,从血液中心到医院为病人治疗的输血专科医生较少。

图2. Paul Ness教授与采访编辑Jessie

采访中(图2),Ness教授谈到,他儿时的梦想其实是工程师,大学时也的确考进了MIT攻读工程。后来经过一段时间的学习,发现自己其实不太感兴趣也不擅长这个行业,却开始对医学产生了浓厚的兴趣,毅然决定弃工程从医,在医学路上一步步走来,越来越热爱与坚定。笔者不禁感叹兴趣导向的重要性与乐趣。

我们了解到,Ness教授积极参与帮助亚非地区建立和管理输血国际项目,也特别热衷于对年轻医师的教育培养。问起他对年轻学者学习和成长的建议,他总结为:多问、多思考、多交益友,终身学习。

Transfusion杂志作为输血领域最有影响力的杂志之一,Ness教授担任其主编多年,一步步见证着该杂志的成长。我们很荣幸邀请到Ness教授加入了旗下杂志Annals of Blood(AOB)编委,共同把AOB打造成血液领域有影响力的国际平台。提到对AOB未来成长的建议,他结合在Transfusion杂志的经验,认为最重要的是,多挖掘引人思考、使人共鸣的主题,通过优质的内容,最终拉近杂志与读者的距离。

更多精彩内容的分享,欢迎观看视频。

采访编辑:钟珊珊,AME Publishing Company

写作编辑:连海玲,AME Publishing Company

视频编辑:陈国豪,AME Publishing Company

comments powered by Disqus

附件